The Federal Trade Commission on Thursday said it was returning $149 million to distributors of AdvoCare who lost money due to a pyramid scheme...

The regulatory actions could have a chilling effect on the U.S. market for delta-8 THC, which FDA says features “intoxicating” and “psychoactive” effects and could harm consumers.

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

FDA said in recently published draft guidance it’s still considering commencing a rulemaking to authorize the use of NAC as a dietary supplement.

Asking a lot of good questions, touring facilities and verifying documentation are but a few of the recommended steps when looking for a contract manufacturing partner.

A Harvard medical professor who studies dietary supplements maintains a bill in the U.S. Senate "is a waste of taxpayer money" and will limit—not further—FDA’s ability to enforce the law.

A young sports nutrition line blends performance science, research, product formulation and brand-building to help people at all levels achieve their athletic and fitness goals.

FDA, which has supported mandatory product listing in previous budget requests to Congress, has said the U.S. market contains as many as 80,000 dietary supplement products.

The majority of Americans take a dietary supplement, yet FDA “can’t even tell us how many dietary supplements are sold in America,” Sen. Dick Durbin said Tuesday. Durbin aims to change that, and more, with a dietary supplement bill that's going to...

FDA and stakeholders in the dietary supplement industry highlighted differences between NAC and CBD, supporting the notion that FDA is unlikely to issue a formal policy of enforcement discretion for CBD-containing products marketed as dietary...